Topic: Health

Scientists have developed a new blood test that can accurately diagnose Alzheimer's disease. The test looks at how proteins are folded in the bloodstream, not just their levels.

Alzheimer's is a serious brain disorder that affects millions of people worldwide. Current tests for diagnosing Alzheimer's look at two main proteins: amyloid beta and phosphorylated tau. However, these tests may not detect the disease early enough. Researchers at Scripps Research have now developed a new test that focuses on how proteins are folded in the bloodstream rather than just their levels.

The team analyzed blood samples from over 500 participants and found that three specific proteins showed strong links to Alzheimer's status. These proteins were C1QA, clusterin, and apolipoprotein B. The researchers used machine learning techniques to identify patterns connected to disease stage.

The new test was able to accurately diagnose Alzheimer's with about 83% overall accuracy. When tested in independent participant groups, the panel identified disease status with about 86% accuracy and reflected changes in diagnosis over time.

Why It Matters

This breakthrough could lead to earlier diagnosis and treatment of Alzheimer's, which is especially important for Indian students who may have family members affected by the disease.

Key Facts

• The new blood test can diagnose Alzheimer's with about 83% overall accuracy
• The test looks at how proteins are folded in the bloodstream, not just their levels
• The test was able to accurately diagnose Alzheimer's in independent participant groups

Key Terms

Proteostasis

The system responsible for keeping proteins properly folded and removing damaged ones

Implications

This breakthrough could lead to earlier diagnosis and treatment of Alzheimer's, which is especially important for Indian students who may have family members affected by the disease.